Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 161: Which one is a contraindication to the use of ergot derivatives?

A. Migraine
B. Hyperprolactinemia
C. Obstructive vascular disease (Correct Answer)
D. Postpartum hemorrhage

Explanation: **Explanation:** Ergot derivatives (e.g., Ergotamine, Ergonovine) act as partial agonists at **α-adrenergic receptors** and 5-HT receptors. Their primary pharmacological effect is **potent and prolonged vasoconstriction**. **1. Why "Obstructive Vascular Disease" is the Correct Answer:** Because ergot alkaloids cause significant peripheral vasoconstriction, they can severely compromise blood flow in patients with pre-existing vascular compromise. In conditions like Buerger’s disease, Raynaud’s phenomenon, or Coronary Artery Disease (CAD), ergot use can precipitate **gangrene or myocardial infarction**. Therefore, obstructive vascular disease is a strict contraindication. **2. Why the Other Options are Incorrect:** * **Migraine:** Ergotamine and Dihydroergotamine (DHE) are actually *indicated* for the treatment of acute migraine attacks due to their ability to constrict dilated cerebral vessels. * **Hyperprolactinemia:** Bromocriptine and Cabergoline (ergot derivatives) are the *drugs of choice* here, as they act as D2-receptor agonists to inhibit prolactin release. * **Postpartum Hemorrhage (PPH):** Methylergometrine is a standard treatment for PPH because it induces powerful uterine contractions (oxytocic effect) to control bleeding. **High-Yield NEET-PG Pearls:** * **Ergotism (St. Anthony’s Fire):** Chronic poisoning characterized by intense burning pain and dry gangrene due to persistent vasoconstriction. * **Drug Interaction:** Avoid using ergots with **Triptans** within 24 hours (risk of additive vasospasm). * **Specific Contraindications:** Pregnancy (due to fetal distress/abortion), Sepsis, and Severe Hypertension. * **Bromocriptine** is also used in Parkinson’s disease and Type 2 Diabetes (Cycloset).

Question 162: What is the most predictive and dangerous side effect of propranolol that makes it to be avoided in a known patient of COPD?

A. Respiratory failure
B. Acute asthmatic attack (Correct Answer)
C. Glaucoma
D. Pleural effusion

Explanation: **Explanation:** The correct answer is **Acute asthmatic attack**. **1. Mechanism of Action:** Propranolol is a **non-selective beta-blocker**, meaning it antagonizes both $\beta_1$ (cardiac) and $\beta_2$ (bronchial, vascular) receptors. In the lungs, $\beta_2$ receptors are responsible for bronchodilation. By blocking these receptors, propranolol prevents the smooth muscle relaxation mediated by endogenous catecholamines. In patients with reactive airway diseases like COPD or Asthma, this leads to unopposed bronchoconstriction, potentially triggering a life-threatening acute asthmatic attack or severe bronchospasm. **2. Analysis of Incorrect Options:** * **A. Respiratory failure:** While severe bronchospasm can lead to respiratory failure, it is a secondary consequence rather than the immediate, predictive side effect triggered by the drug’s pharmacological action. * **C. Glaucoma:** Propranolol (and other beta-blockers like Timolol) actually *reduces* intraocular pressure by decreasing aqueous humor production; therefore, it is used to treat glaucoma, not a side effect of it. * **D. Pleural effusion:** This is an accumulation of fluid in the pleural space, typically caused by heart failure, infection, or malignancy. It is not a recognized side effect of beta-blocker therapy. **Clinical Pearls for NEET-PG:** * **Cardioselectivity:** In patients with respiratory comorbidities, "cardioselective" $\beta_1$ blockers (e.g., **Metoprolol, Atenolol, Bisoprolol**) are preferred, though they should still be used with extreme caution at low doses. * **Mnemonic for Cardioselective Blockers:** **"New Beta Blockers Act Mainly On Heart"** (Nebivolol, Betaxolol, Bisoprolol, Acebutolol, Metoprolol, Atenolol). * **Absolute Contraindication:** Non-selective beta-blockers are absolutely contraindicated in patients with active bronchial asthma.

Question 163: Which anticholinesterase inhibitor binds to the anionic site?

A. Physostigmine
B. Edrophonium (Correct Answer)
C. Neostigmine
D. Echothiophate

Explanation: **Explanation:** The enzyme **Acetylcholinesterase (AChE)** has two primary binding domains: the **anionic site** (which attracts the quaternary ammonium group of acetylcholine) and the **esteratic site** (where the actual hydrolysis occurs). **Why Edrophonium is Correct:** Edrophonium is a quaternary ammonium compound that binds **non-covalently** (via hydrogen bonding and electrostatic attraction) specifically to the **anionic site** of the enzyme. Because it does not form a covalent bond and does not involve the esteratic site, its action is very brief (5–15 minutes). This makes it ideal for the "Tensilon Test." **Analysis of Incorrect Options:** * **Physostigmine & Neostigmine:** These are carbamates. They bind to **both the anionic and esteratic sites**. They form a carbamoylated enzyme complex at the esteratic site, which is more resistant to hydrolysis than the acetylated enzyme, leading to a longer duration of action (0.5–6 hours). * **Echothiophate:** This is an organophosphate. It binds covalently only to the **esteratic site**, forming a stable phosphorylated enzyme complex. This bond is extremely strong and can become irreversible through a process called "aging." **NEET-PG High-Yield Pearls:** * **Edrophonium:** Used in the **Tensilon Test** to differentiate between Myasthenic crisis (improvement) and Cholinergic crisis (worsening). * **Physostigmine:** The only clinically used tertiary amine anticholinesterase; it **crosses the blood-brain barrier** and is the drug of choice for Atropine poisoning. * **Neostigmine:** A quaternary amine (no CNS entry); used for Myasthenia Gravis and reversing neuromuscular blockade (curare poisoning). * **Mechanism Summary:** * *Simple competitive (Anionic only):* Edrophonium. * *Acid-transferring (Both sites):* Carbamates. * *Irreversible (Esteratic only):* Organophosphates.

Question 164: Choline esters like carbachol are most likely to cause which of the following adverse effects?

A. Delirium
B. Anhydrosis (dry skin)
C. Salivation (Correct Answer)
D. Tachycardia

Explanation: **Explanation:** Carbachol is a **direct-acting cholinergic agonist** (choline ester) that stimulates both muscarinic (M) and nicotinic (N) receptors. The adverse effect profile of such drugs is a direct extension of their parasympathomimetic actions, often summarized by the mnemonic **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation). **Why Salivation is Correct:** Cholinergic drugs stimulate **M3 receptors** located on exocrine glands. Activation of these receptors on salivary glands leads to increased secretions (sialorrhea). This is a classic "SLUDGE" (Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis) sign of cholinergic excess. **Analysis of Incorrect Options:** * **A. Delirium:** This is a feature of **Atropine poisoning** (anticholinergic toxicity), often described as "Mad as a hatter." Choline esters like carbachol are quaternary ammonium compounds; they are highly polar and do not easily cross the blood-brain barrier to cause CNS effects like delirium. * **B. Anhydrosis:** Cholinergic drugs cause **diaphoresis** (excessive sweating) via M3 receptors on eccrine sweat glands. Anhydrosis (dry skin) is a side effect of anticholinergics (e.g., Atropine). * **C. Tachycardia:** Parasympathetic stimulation typically causes **bradycardia** (via M2 receptors in the SA node). Tachycardia is a sympathetic response or a result of muscarinic blockade. **High-Yield Clinical Pearls for NEET-PG:** * **Carbachol vs. Bethanechol:** Carbachol has both Muscarinic and Nicotinic activity, whereas Bethanechol is purely Muscarinic. * **Resistance:** Unlike Acetylcholine, Carbachol is resistant to hydrolysis by both acetylcholinesterase and pseudocholinesterase, leading to a prolonged duration of action. * **Clinical Use:** Carbachol is primarily used topically in the eye to produce miosis and reduce intraocular pressure in glaucoma.

Question 165: Which of the following cranial nerves does not contain parasympathetic motor (GVE) fibers?

A. III
B. VI (Correct Answer)
C. IX
D. X

Explanation: **Explanation:** The parasympathetic nervous system (craniosacral outflow) originates from specific nuclei in the brainstem and the sacral spinal cord (S2-S4). The cranial component consists of four specific cranial nerves that carry **General Visceral Efferent (GVE)** fibers to various ganglia. **1. Why Option B (VI) is correct:** The **Abducens nerve (CN VI)** is a purely somatic motor nerve. Its only function is to provide motor innervation to the Lateral Rectus muscle of the eye. It does **not** carry any autonomic (parasympathetic) fibers. **2. Why the other options are incorrect:** * **CN III (Oculomotor):** Carries parasympathetic fibers from the **Edinger-Westphal nucleus** to the ciliary ganglion. These fibers control the sphincter pupillae (miosis) and ciliary muscles (accommodation). * **CN IX (Glossopharyngeal):** Carries fibers from the **Inferior Salivatory nucleus** via the lesser petrosal nerve to the otic ganglion, providing secretomotor supply to the **parotid gland**. * **CN X (Vagus):** Carries the bulk of the body's parasympathetic outflow from the **Dorsal Motor Nucleus** and Nucleus Ambiguus to the thoracic and abdominal viscera (heart, lungs, and GI tract up to the splenic flexure). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic "1973":** Remember the numbers **10, 9, 7, and 3** to recall the cranial nerves with parasympathetic outflow. * **CN VII (Facial):** Not listed here, but it carries fibers from the **Superior Salivatory nucleus** to the submandibular and pterygopalatine ganglia (supplying submandibular, sublingual, and lacrimal glands). * **Ciliary Ganglion** is associated with CN III; **Pterygopalatine/Submandibular** with CN VII; **Otic** with CN IX.

Question 166: What is the mechanism of action of botulinum toxin?

A. Increased cAMP
B. Increased cGMP
C. Inhibition of acetylcholine release (Correct Answer)
D. Inhibition of noradrenaline release

Explanation: **Explanation:** **Mechanism of Action:** Botulinum toxin, produced by the bacterium *Clostridium botulinum*, is a potent neurotoxin that acts at the presynaptic nerve terminal of cholinergic neurons. Its primary mechanism is the **inhibition of acetylcholine (ACh) release** into the synaptic cleft. The toxin works by cleaving **SNARE proteins** (specifically SNAP-25, synaptobrevin, or syntaxin). These proteins are essential for the docking and fusion of ACh-containing vesicles with the presynaptic membrane. By preventing this fusion, the toxin causes a chemical denervation, leading to flaccid paralysis of the muscle. **Analysis of Incorrect Options:** * **Options A & B (Increased cAMP/cGMP):** These are common second messengers for G-protein coupled receptors (e.g., Beta-receptors or Nitric Oxide pathways). Botulinum toxin does not interact with intracellular cyclic nucleotides. * **Option D (Inhibition of noradrenaline release):** This is the mechanism of drugs like **Guanethidine** or **Bretylium**. Botulinum toxin is specific to cholinergic fibers (parasympathetic and somatic motor nerves), not adrenergic fibers. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Uses:** Used for focal dystonias (Blepharospasm, Torticollis), Achalasia cardia, Hyperhidrosis, Strabismus, and cosmetic reduction of wrinkles. * **Botulism:** Foodborne botulism (ingestion of preformed toxin) or Infant botulism ("Floppy Baby Syndrome" from honey spores) presents with descending paralysis and diplopia. * **Antidote:** Treatment involves the administration of antitoxin; however, it only neutralizes unbound toxin and cannot reverse existing paralysis.

Question 167: Sildenafil acts by inhibiting which enzyme?

A. Phosphodiesterase 2 (PDE 2)
B. Phosphodiesterase 5 (PDE 5) (Correct Answer)
C. Adenyl cyclase
D. Guanylyl cyclase

Explanation: **Explanation:** **Mechanism of Action:** Sildenafil is a selective inhibitor of **Phosphodiesterase 5 (PDE 5)**. In the corpus cavernosum of the penis, sexual stimulation leads to the release of Nitric Oxide (NO), which activates guanylyl cyclase to produce **cyclic GMP (cGMP)**. cGMP causes smooth muscle relaxation and increased blood flow, resulting in an erection. Under normal physiological conditions, PDE 5 breaks down cGMP. By inhibiting PDE 5, Sildenafil prevents the degradation of cGMP, thereby enhancing and prolonging the vasodilatory effect. **Analysis of Incorrect Options:** * **PDE 2:** This enzyme is primarily involved in the regulation of cAMP and cGMP in the brain and adrenal glands; it is not the target for erectile dysfunction drugs. * **Adenyl Cyclase:** This enzyme converts ATP to cAMP (the second messenger for beta-adrenergic receptors). Sildenafil acts on the cGMP pathway, not the cAMP pathway. * **Guanylyl Cyclase:** This is the enzyme that *produces* cGMP. Sildenafil does not inhibit it; rather, it works downstream by preventing the breakdown of the product (cGMP) formed by this enzyme. **High-Yield NEET-PG Pearls:** * **Clinical Uses:** Erectile dysfunction and Pulmonary Arterial Hypertension (PAH). * **Drug Interaction:** Strictly contraindicated with **Nitrates** (e.g., Nitroglycerin) as it can lead to severe, life-threatening hypotension due to synergistic increases in cGMP. * **Side Effects:** Headache, flushing, and **Cyanopsia** (blue-tinted vision) due to cross-inhibition of PDE 6 in the retina. * **Tadalafil vs. Sildenafil:** Tadalafil has a longer half-life (approx. 18 hours), often referred to as the "weekend pill."

Question 168: What is the effect of cocaine on blood vessels?

A. Vasoconstrictor (Correct Answer)
B. Vasodilator
C. Vasoineffective
D. First constricts then dilates

Explanation: ### Explanation **1. Why Option A is Correct:** Cocaine acts as an indirect-acting sympathomimetic. Its primary mechanism is the **inhibition of the Reuptake-1 transporter (NET)** at the presynaptic nerve terminal. This prevents the reabsorption of norepinephrine (NE) from the synaptic cleft, leading to a significant increase in NE concentration. This excess NE stimulates **$\alpha_1$-adrenergic receptors** on the vascular smooth muscle, resulting in potent **vasoconstriction**. **2. Why Other Options are Incorrect:** * **Option B (Vasodilator):** Cocaine does not stimulate $\beta_2$ receptors or release nitric oxide to a degree that would cause vasodilation. Its dominant effect is $\alpha$-mediated constriction. * **Option C (Vasoineffective):** Cocaine has profound cardiovascular effects, including hypertension and tachycardia; it is never hemodynamically neutral. * **Option D (First constricts then dilates):** This describes a "biphasic response" (like low-dose epinephrine). Cocaine’s effect is consistently vasoconstrictive due to the sustained presence of NE in the synapse. **3. High-Yield Clinical Pearls for NEET-PG:** * **Local Anesthetic Exception:** Cocaine is the **only** local anesthetic that is a vasoconstrictor. All other local anesthetics (e.g., Lidocaine) are vasodilators. * **Clinical Use:** Due to its vasoconstrictive and anesthetic properties, it is used topically in ENT surgeries (e.g., rhinoplasty) to reduce bleeding. * **Contraindication:** Never use **$\beta$-blockers** (like Propranolol) in cocaine toxicity. Blocking $\beta_2$ (vasodilation) leaves $\alpha_1$ stimulation unopposed, leading to a hypertensive crisis and coronary vasospasm (Prinzmetal angina). * **Organ Damage:** Chronic use causes midline destructive lesions (septal perforation) due to ischemic necrosis from prolonged vasoconstriction.

Question 169: Dale's vasomotor reversal is explained by the stimulation of which type of adrenergic receptor?

A. Alpha-1 receptors
B. Alpha-2 receptors
C. Beta-1 receptors
D. Beta-2 receptors (Correct Answer)

Explanation: ### Explanation: Dale’s Vasomotor Reversal **Concept Overview:** Dale’s vasomotor reversal (or the "Dale Phenomenon") describes the paradoxical fall in blood pressure observed when **Adrenaline** is administered after an **Alpha-blocker** (e.g., Ergotoxine or Phentolamine) [1]. Normally, Adrenaline stimulates both Alpha (α) and Beta (β) receptors. Since α-receptors (vasoconstriction) are more potent than β-receptors (vasodilation), the net effect is a rise in blood pressure. However, when α-receptors are blocked, the vasoconstrictor effect is abolished. This "unmasks" the latent vasodilatory action of Adrenaline mediated by **Beta-2 (β2) receptors** in the skeletal muscle vasculature, leading to a significant drop in blood pressure [1]. **Analysis of Options:** * **D. Beta-2 receptors (Correct):** These receptors are responsible for vasodilation. In the presence of an α-blocker, Adrenaline acts exclusively on these receptors to lower peripheral resistance [1, 2]. * **A. Alpha-1 receptors:** These mediate vasoconstriction. Their blockade is the *prerequisite* for Dale’s reversal, but their stimulation causes the initial rise in BP, not the reversal [1, 2]. * **B. Alpha-2 receptors:** While these can influence BP via central mechanisms or presynaptic inhibition, they are not the primary mediators of the peripheral vasodilatory "reversal" effect. * **C. Beta-1 receptors:** These primarily affect the heart (increasing heart rate and contractility). While they contribute to cardiac output, they do not cause the peripheral vasodilation seen in this phenomenon. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice:** Dale’s reversal is classically demonstrated using **Adrenaline**. It cannot be demonstrated with **Noradrenaline** because Noradrenaline lacks significant β2 activity. 2. **Clinical Relevance:** This explains why non-selective α-blockers can cause profound hypotension if Adrenaline is subsequently administered. 3. **Key Receptors:** Remember: **α1 = Constriction; β2 = Dilation.** Reversal = "Unmasking" of β2 [1, 2].

Question 170: Dale's vasomotor reversal phenomenon occurs with which of the following?

A. Dopamine
B. Adrenaline (Correct Answer)
C. Noradrenaline
D. All of the above

Explanation: **Explanation:** **Dale’s Vasomotor Reversal** (also known as the Dale’s Phenomenon) refers to the paradoxical fall in blood pressure when Adrenaline is administered after an alpha-blocker (like Phentolamine or Ergotoxine). **1. Why Adrenaline is correct:** Adrenaline acts on both **α-receptors** (vasoconstriction) and **β2-receptors** (vasodilation). Under normal conditions, the α-response predominates, leading to a rise in blood pressure. However, if an α-blocker is given first, the α-receptors are occupied. When Adrenaline is subsequently administered, it can only act on the "unmasked" β2-receptors in the skeletal muscle blood vessels, leading to profound vasodilation and a **fall in blood pressure** (reversal of the usual pressor effect). **2. Why other options are incorrect:** * **Noradrenaline:** It acts primarily on α1, α2, and β1 receptors with **negligible action on β2 receptors**. Therefore, even after α-blockade, there is no significant β2-mediated vasodilation to cause a fall in BP. * **Dopamine:** While Dopamine has complex dose-dependent effects, it does not typically exhibit the classic "vasomotor reversal" described by Dale, which specifically characterizes the dual α and β2 nature of Adrenaline. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Adrenaline":** Small dose = β effect (Vasodilation); Large dose = α effect (Vasoconstriction). * **Vasomotor Reversal of Sir Henry Dale** is the classic pharmacological demonstration of the dual nature of Adrenaline. * **Clinical Application:** In patients with Pheochromocytoma, always give an **α-blocker before a β-blocker** to prevent a hypertensive crisis caused by unopposed α-stimulation.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free